• Je něco špatně v tomto záznamu ?

Diagnosing Czech Patients with Inherited Platelet Disorders

J. Louzil, J. Stikarova, D. Provaznikova, I. Hrachovinova, T. Fenclova, J. Musil, M. Radek, J. Kaufmanova, V. Geierova, E. Ceznerova, P. Salaj, R. Kotlin

. 2022 ; 23 (22) : . [pub] 20221119

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032625

A single-center study was conducted on 120 patients with inherited disorders of primary hemostasis followed at our hematological center. These patients presented a variety of bleeding symptoms; however, they had no definitive diagnosis. Establishing a diagnosis has consequences for the investigation of probands in families and for treatment management; therefore, we aimed to improve the diagnosis rate in these patients by implementing advanced diagnostic methods. According to the accepted international guidelines at the time of study, we investigated platelet morphology, platelet function assay, light-transmission aggregometry, and flow cytometry. Using only these methods, we were unable to make a definitive diagnosis for most of our patients. However, next-generation sequencing (NGS), which was applied in 31 patients, allowed us to establish definitive diagnoses in six cases (variants in ANKRD26, ITGA2B, and F8) and helped us to identify suspected variants (NBEAL2, F2, BLOC1S6, AP3D1, GP1BB, ANO6, CD36, and ITGB3) and new suspected variants (GFI1B, FGA, GP1BA, and ITGA2B) in 11 patients. The role of NGS in patients with suspicious bleeding symptoms is growing and it changes the diagnostic algorithm. The greatest disadvantage of NGS, aside from the cost, is the occurrence of gene variants of uncertain significance.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032625
003      
CZ-PrNML
005      
20230131150743.0
007      
ta
008      
230120s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms232214386 $2 doi
035    __
$a (PubMed)36430862
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Louzil, Jan $u Centre for Thrombosis and Hemostasis, Institute of Hematology and Blood Transfusion, 128 20 Prague, Czech Republic
245    10
$a Diagnosing Czech Patients with Inherited Platelet Disorders / $c J. Louzil, J. Stikarova, D. Provaznikova, I. Hrachovinova, T. Fenclova, J. Musil, M. Radek, J. Kaufmanova, V. Geierova, E. Ceznerova, P. Salaj, R. Kotlin
520    9_
$a A single-center study was conducted on 120 patients with inherited disorders of primary hemostasis followed at our hematological center. These patients presented a variety of bleeding symptoms; however, they had no definitive diagnosis. Establishing a diagnosis has consequences for the investigation of probands in families and for treatment management; therefore, we aimed to improve the diagnosis rate in these patients by implementing advanced diagnostic methods. According to the accepted international guidelines at the time of study, we investigated platelet morphology, platelet function assay, light-transmission aggregometry, and flow cytometry. Using only these methods, we were unable to make a definitive diagnosis for most of our patients. However, next-generation sequencing (NGS), which was applied in 31 patients, allowed us to establish definitive diagnoses in six cases (variants in ANKRD26, ITGA2B, and F8) and helped us to identify suspected variants (NBEAL2, F2, BLOC1S6, AP3D1, GP1BB, ANO6, CD36, and ITGB3) and new suspected variants (GFI1B, FGA, GP1BA, and ITGA2B) in 11 patients. The role of NGS in patients with suspicious bleeding symptoms is growing and it changes the diagnostic algorithm. The greatest disadvantage of NGS, aside from the cost, is the occurrence of gene variants of uncertain significance.
650    _2
$a lidé $7 D006801
650    12
$a trombocytopatie $x diagnóza $x genetika $7 D001791
650    _2
$a vyšetření funkce trombocytů $7 D010979
650    _2
$a vysoce účinné nukleotidové sekvenování $7 D059014
650    _2
$a krvácení $7 D006470
650    _2
$a krevní proteiny $x genetika $7 D001798
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Stikarova, Jana $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, 128 20 Prague, Czech Republic $1 https://orcid.org/0000000259640526
700    1_
$a Provaznikova, Dana $u Laboratory for Disorders in Hemostasis, Institute of Hematology and Blood Transfusion, 128 20 Prague, Czech Republic $1 https://orcid.org/0000000321498242
700    1_
$a Hrachovinova, Ingrid $u Laboratory for Disorders in Hemostasis, Institute of Hematology and Blood Transfusion, 128 20 Prague, Czech Republic
700    1_
$a Fenclova, Tereza $u Laboratory for Disorders in Hemostasis, Institute of Hematology and Blood Transfusion, 128 20 Prague, Czech Republic
700    1_
$a Musil, Jan $u Department of Immunomonitoring and Flow Cytometry, Institute of Hematology and Blood Transfusion, 128 20 Prague, Czech Republic
700    1_
$a Radek, Martin $u Central Hematology Laboratories, Institute of Medical Biochemistry and Laboratory Diagnostics of the General University Hospital and of the First Faculty of Medicine of Charles University, 128 20 Prague, Czech Republic $1 https://orcid.org/0000000229675349
700    1_
$a Kaufmanova, Jirina $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, 128 20 Prague, Czech Republic $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technicka 5, 166 28 Prague, Czech Republic $1 https://orcid.org/0000000303378204
700    1_
$a Geierova, Vera $u Centre for Thrombosis and Hemostasis, Institute of Hematology and Blood Transfusion, 128 20 Prague, Czech Republic
700    1_
$a Ceznerova, Eliska $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, 128 20 Prague, Czech Republic $1 https://orcid.org/0000000210725967
700    1_
$a Salaj, Peter $u Centre for Thrombosis and Hemostasis, Institute of Hematology and Blood Transfusion, 128 20 Prague, Czech Republic
700    1_
$a Kotlin, Roman $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, 128 20 Prague, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 23, č. 22 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36430862 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131150739 $b ABA008
999    __
$a ok $b bmc $g 1891407 $s 1183960
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 23 $c 22 $e 20221119 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace